Europe — EMA
Pantoprazol Krka (Pantoprazole)
Pantoprazole, the active ingredient in Pantoprazol Krka, is a proton pump inhibitor presented as a tablet for oral use. It reduces stomach acid production and is used to treat conditions such as gastro‑oesophageal…
Request sourcing
What is Pantoprazole?
Pantoprazole, the active ingredient in Pantoprazol Krka, is a proton pump inhibitor presented as a tablet for oral use. It reduces stomach acid production and is used to treat conditions such as gastro‑oesophageal reflux disease and peptic ulcer disease in adults.
GNH USA supplies Pantoprazol Krka as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.
What is Pantoprazole used for?
Pantoprazol Krka is a proton‑pump inhibitor that acts on the gastric acid secretion pathway. It is indicated for: - Gastro‑oesophageal reflux disease (GERD): Improves symptoms and promotes healing of the oesophageal lining. - Erosive esophagitis: Heals erosive lesions and reduces further damage. - Peptic ulcer disease: Facilitates ulcer healing and reduces recurrence. - Zollinger‑Ellison syndrome: Controls excessive gastric acid secretion associated with the syndrome.
What are the side effects of Pantoprazole?
Pantoprazol Krka is generally well tolerated, but adverse reactions can occur.
Common Side Effects: - Headache: mild to moderate intensity. - Diarrhoea: usually self‑limiting. - Abdominal pain: discomfort in the stomach region. - Nausea: occasional feeling of queasiness. - Flatulence: increased intestinal gas. - Constipation: reduced bowel movements.
Serious or Rare Side Effects: - Severe hypersensitivity reactions: rash, itching, swelling, or anaphylaxis. - Clostridioides difficile infection: persistent watery diarrhoea. - Low magnesium levels (hypomagnesemia): muscle cramps, irregular heartbeat. - Bone fractures: increased risk with long‑term use. - Acute interstitial nephritis: kidney inflammation. - Liver enzyme abnormalities: elevated ALT/AST.
What precautions apply to Pantoprazole?
When prescribing Pantoprazol Krka, clinicians should consider several safety aspects.
- Assess risk of osteoporosis and fracture in long‑term users: - Evaluate the potential for drug interactions with warfar and clopidogrel as the risk of c: - Evaluate the treatment duration and the ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... - ");
Product details
Related products

PANTOPRAZOLE SODIUM 20 mg/1
Pantoprazole · 20 mg

PANTOPRAZOLE SODIUM 20 mg/1
Pantoprazole · 20 mg

PANTOPRAZOLE SODIUM 20 mg/1
Pantoprazole · 20 mg

PANTOPRAZOLE SODIUM 40 mg/1
Pantoprazole · 40 mg